Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Gives Firms Hawking H1N1 Remedies Tighter Deadline To Comply

This article was originally published in The Tan Sheet

Executive Summary

FDA's threats of near-immediate action against firms selling products with claims of treating the 2009-H1N1 flu virus are the sign of a fleet-footed and serious agency, says a food and drug attorney

You may also be interested in...



In Brief

Valeant picks up skin care OTCs from J&J; FDA finds ‘supplements’ making anti-meningitis claims; Capsugel supplies Mercola.com; investigation charge slows Omega Protein; Vitacost continues diversifying sales mix more news in brief.

AHPA Says H1N1 Enforcement Tactics Would Work To Find Hidden Steroids

The American Herbal Products Association urges FDA to crack down on illegal steroids masquerading as dietary supplements with the "efficient" enforcement tactics the agency uses to pursue fraudulent H1N1 flu products

AHPA Says H1N1 Enforcement Tactics Would Work To Find Hidden Steroids

The American Herbal Products Association urges FDA to crack down on illegal steroids masquerading as dietary supplements with the "efficient" enforcement tactics the agency uses to pursue fraudulent H1N1 flu products

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS102942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel